PATENTED MATERIAL

Ingredient evidence. Before formulation.

Selected from QOEM’s ingredient catalog using exact-ingredient patent and U.S. documentation. Final suitability depends on the supplied grade, dose, population and intended use.

PATENTED INGREDIENT · U.S. NDI RECORD

Pep2Dia®

Whey protein hydrolysate · Ingredia, France

The manufacturer reports U.S. NDI status; FDA’s inventory lists Pep2Dia under NDIN 1201. This confirms a notification record, not FDA approval of an ingredient or finished product.

Discuss this ingredient

Patent evidence

Manufacturer identifies Pep2Dia as patented. QOEM lists WO2015/124867 and EP3107556; these are not presented as U.S. patents.

U.S. record

NDIN 1201 · Ingredia SA. Submission: March 23, 2021. FDA response date: May 28, 2021.

Before a production quote

Confirm the exact supplied ingredient, dossier conditions, milk allergen labeling and authorized supply. FDA response content must be checked before final U.S.-use clearance.

Source documents

QOEM ingredient listing Ingredia manufacturer information FDA NDI inventory · entry 1201

No other catalog ingredient is currently shown as cleared for U.S. use. A missing listing means supporting documentation has not been established here, not that the ingredient is prohibited.